Project Number 5R01AG065246-02 Agency/Funding Organization NIA Funding Year 2021 View Full Project Details for Citalopram as a posterior cortical protective therapy in Parkinson disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) r. Multi-target Researcher and Organization Principal Investigator KOTAGAL, VIKAS Principal Investigator First Name KOTAGAL Principal Investigator Last Name VIKAS Awardee Organization UNIVERSITY OF MICHIGAN Awardee State Michigan Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-877: Early Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Optional) FY Overall Cost $741,668 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official ST HILLAIRE-CLARKE, CORYSE
